Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
China · Delayed Price · Currency is CNY 9.87
-0.09 (-0.90%)
Apr 17, 2026, 3:04 PM CST
SHE:300009 Revenue
In the year 2025, Anhui Anke Biotechnology (Group) had annual revenue of 2.65B CNY with 4.36% growth. Anhui Anke Biotechnology (Group) had revenue of 683.93M in the quarter ending December 31, 2025, with 11.25% growth.
Revenue
2.65B
Revenue Growth
+4.36%
P/S Ratio
6.22
Revenue / Employee
1.06M
Employees
2,505
Market Cap
16.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.65B | 110.48M | 4.36% |
| Dec 31, 2024 | 2.54B | -329.71M | -11.51% |
| Dec 31, 2023 | 2.87B | 534.69M | 22.94% |
| Jan 1, 2023 | 2.33B | 162.30M | 7.48% |
| Dec 31, 2021 | 2.17B | 467.35M | 27.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chengzhi | 10.87B |
| Tibet Cheezheng Tibetan Medicine | 2.42B |
| Pacific Shuanglin Bio-pharmacy | 2.38B |
| Inner Mongolia Furui Medical Science | 1.60B |
| Sinocelltech Group | 1.56B |
| Vcanbio Cell & Gene Engineering Corp., | 1.47B |
| Jinyu Bio-technology | 1.33B |
| Hualan Biological Vaccine | 1.20B |